52 Week HighGlenmark has hit a 52wk high of Rs 665.90 on NSE
52 Week HighGlenmark has hit a 52wk high of Rs 641.90 on NSE
AnnouncementsGlenmark Pharmaceuticals: Outcome of AGM
AnnouncementsGlenmark Pharmaceuticals: Outcome of board meeting
50% of moneycontrol users recommend buying Glenmark.
What's your call on Glenmark today?
Read 9 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2824.00||0.06||2939.80||2140.35||48,102.62|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
Jindal PolyFilms Recommended on May 27th 2014
Recommended price 177.00 | Peak from reco 278.40 57.29%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Glenmark is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 17,811.90 crore.The company has reported a consolidated sales of Rs 1,477.82 crore and a Net Profit of Rs 184.90 crore for the quarter ended Jun 2014.
The company management includes Glenn Saldanha - Chairman & Managing Director, Rajesh V Desai - Executive Director & CFO, Cherylann Pinto - Director - Corporate Affairs, D R Mehta - Non Executive Director, Bernard Munos - Non Executive Director, J F Ribeiro - Non Executive Director, Brian W Tempest - Non Executive Director, Sridhar Gorthi - Non Executive Director, Hocine Sidi Said - Non Executive Director, N B Desai - Non Executive Director.
It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.
Its Registered office is at B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai,Maharashtra - 400026.
Their Registrars are Karvy Computershare Private Ltd.